Atezolizumab and Bevacizumab for Treatment of Patients With Unresectable / Non-transplantable Advanced Hepatocellular Carcinoma: A Real-World Single Center Experience from North India

被引：1
作者：
Dhampalwar, Swapnil [1 ,2 ]
Choudhary, Narendra S. [1 ]
Saraf, Neeraj [1 ]
Bhangui, Prashant [1 ]
Soin, Arvinder S. [1 ]
机构：
[1] Medanta Medicity, Inst Liver Transplantat & Regenerat Med, Gurugram, India
[2] Medanta Medicity, Medanta Inst Liver Transplantat & Regenerat Med, Consultant Transplant Hepatol, Sect 38, Gurgaon, India
来源：
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY | 2024年 / 14卷 / 01期
关键词：
PLUS BEVACIZUMAB;
D O I：
10.1016/j.jceh.2023.07.006
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 6 条
  • [1] A Meta-Analysis of Survival Rates of Untreated Patients in Randomized Clinical Trials of Hepatocellular Carcinoma
    Cabibbo, Giuseppe
    Enea, Marco
    Attanasio, Massimo
    Bruix, Jordi
    Craxi, Antonio
    Camma, Calogero
    [J]. HEPATOLOGY, 2010, 51 (04) : 1274 - 1283
  • [2] Preliminary evidence of safety and tolerability of atezolizumab plus bevacizumab in patients with hepatocellular carcinoma and Child-Pugh A and B cirrhosis: A real-world study
    D'Alessio, Antonio
    Fulgenzi, Claudia Angela Maria
    Nishida, Naoshi
    Schoenlein, Martin
    von Felden, Johann
    Schulze, Kornelius
    Wege, Henning
    Gaillard, Vincent E.
    Saeed, Anwaar
    Wietharn, Brooke
    Hildebrand, Hannah
    Wu, Linda
    Ang, Celina
    Marron, Thomas U.
    Weinmann, Arndt
    Galle, Peter R.
    Bettinger, Dominik
    Bengsch, Bertram
    Vogel, Arndt
    Balcar, Lorenz
    Scheiner, Bernhard
    Lee, Pei-Chang
    Huang, Yi-Hsiang
    Amara, Suneetha
    Muzaffar, Mahvish
    Naqash, Abdul Rafeh
    Cammarota, Antonella
    Personeni, Nicola
    Pressiani, Tiziana
    Sharma, Rohini
    Pinter, Matthias
    Cortellini, Alessio
    Kudo, Masatoshi
    Rimassa, Lorenza
    Pinato, David J.
    [J]. HEPATOLOGY, 2022, 76 (04) : 1000 - 1012
  • [3] Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience
    de Castro, Tiago
    Jochheim, Leonie S.
    Bathon, Melanie
    Welland, Sabrina
    Scheiner, Bernhard
    Shmanko, Kateryna
    Roessler, Daniel
    Ben Khaled, Najib
    Jeschke, Matthias
    Ludwig, Johannes M.
    Marquardt, Jens U.
    Weinmann, Arndt
    Pinter, Matthias
    Lange, Christian M.
    Vogel, Arndt
    Saborowski, Anna
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [4] Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
    Finn, Richard S.
    Qin, Shukui
    Ikeda, Masafumi
    Galle, Peter R.
    Ducreux, Michel
    Kim, Tae-You
    Kudo, Masatoshi
    Breder, Valeriy
    Merle, Philippe
    Kaseb, Ahmed O.
    Li, Daneng
    Verret, Wendy
    Xu, Derek-Zhen
    Hernandez, Sairy
    Liu, Juan
    Huang, Chen
    Mulla, Sohail
    Wang, Yulei
    Lim, Ho Yeong
    Zhu, Andrew X.
    Cheng, Ann-Lii
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (20) : 1894 - 1905
  • [5] Safety and Efficacy of Atezolizumab-Bevacizumab in Real World: The First Indian Experience
    Kulkarni, Anand, V
    Krishna, Vamsi
    Kumar, Karan
    Sharma, Mithun
    Patodiya, Bharat
    Khan, Arif
    Shaik, Sameer
    Pasumarthy, Ashirwad
    Chhabra, Prateek
    Da, Pramod Kumar
    Saraswat, Vivek A.
    Rao, Padaki N.
    Reddy, Duvvur N.
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 13 (04) : 618 - 623
  • [6] Experience With LDLT in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis Postdownstaging
    Soin, Arvinder S.
    Bhangui, Prashant
    Kataria, Tejinder
    Baijal, Sanjay S.
    Piplani, Tarun
    Gautam, Dheeraj
    Choudhary, Narendra S.
    Thiagarajan, Srinivasan
    Rastogi, Amit
    Saraf, Neeraj
    Saigal, Sanjiv
    [J]. TRANSPLANTATION, 2020, 104 (11) : 2334 - 2345
1